
Improving Synthetic Corneal Grafts: Detecting Residual LAP Photoinitiators
Ensuring ophthalmic hydrogel crosslinking safety is a vital step toward creating reliable alternatives to human donor corneas. Currently, the global shortage of donor tissue significantly restricts corneal transplantation procedures. While one donor cornea can occasionally assist two recipients, the supply still fails to meet growing clinical demand. Furthermore, natural grafts carry inherent risks of infection and cellular rejection. Therefore, researchers are exploring acellular synthetic materials produced through extrusion bioprinting. These innovative materials rely on photocrosslinking to achieve the mechanical stability required for ocular use.
Enhancing Ophthalmic Hydrogel Crosslinking Safety with Spectrophotometry
A recent breakthrough identifies a reliable method to monitor the photoinitiator Lithium Phenyl (2,4,6-Trimethylbenzoyl) Phosphinate (LAP). Although LAP is common in bioprinting, residual non-radicalized molecules can be cytotoxic to ocular cells. Scientists have now demonstrated that spectrophotometry can detect these residuals at a specific wavelength of 372 nm. This measurement depends directly on the LAP concentration within the hydrogel. Thus, it provides a simple way to evaluate crosslinked materials and prevent potential side effects. By correcting these formulations before implantation, clinicians can ensure better outcomes for patients receiving synthetic grafts.
Clinical Significance for Corneal Surgery
This detection method simplifies the verification of synthetic graft safety. It ensures that the crosslinking process is complete and the final material is biocompatible. For medical practitioners in India, where the burden of corneal disease is high, such innovations represent a significant step toward lab-grown solutions. Monitoring chemical residuals effectively reduces the risk of inflammation and graft failure. Consequently, this technique bridges the gap between bioengineering and safe clinical application.
Frequently Asked Questions
What is LAP in ophthalmic bioprinting?
LAP is a water-soluble photoinitiator used to harden hydrogels during the bioprinting of synthetic corneal grafts using light.
Why is residual LAP a safety concern?
Residual or non-radicalized LAP can cause cytotoxic effects, potentially damaging the surrounding ocular tissue after transplantation.
How does spectrophotometry detect LAP?
It measures the absorbance of the material at 372 nm, where the non-radicalized LAP crosslinker has specific characteristics that correlate with its concentration.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or substitute for professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
- Jansen PA et al. Spectrophotometric determination of LAP photoinitiator radicalization in ophthalmic applications. Biomed Mater. 2026 Feb 25. doi: 10.1088/1748-605X/ae4a62. PMID: 41740186.
- Nguyen A, et al. Toxicity and photosensitizing assessment of gelatin methacryloyl-based hydrogels photoinitiated with lithium phenyl-2,4,6-trimethylbenzoylphosphinate in human primary renal proximal tubule epithelial cells. Biomed Mater. 2020;15(5):055027.
- Williams DF. On the nature of biomaterials. Biomaterials. 2009;30(30):5897-5909.

More from MedShots Daily

Researchers have developed a spectrophotometric method to detect residual LAP photoinitiators in synthetic corneal grafts, improving safety in ophthalmology...
2 months ago

A new study evaluates LLMs like GPT-4o in MSI oncology, finding that RAG architectures are essential for clinical reliability and patient safety....
Today

A study across SEAR and WPR reveals that only 22.6% of countries routinely collect pregnancy data in TB surveillance, highlighting urgent gaps in maternal c...
Today

A new study explores how periodontitis exacerbates atherosclerosis through inflammatory responses and macrophage pyroptosis via the NF-κB/NLRP3 pathway....
Today

A study shows that 12 sessions of neuromuscular training over four weeks improves functional performance and reduces ACL injury risk in collegiate athletes....
Today

Two-year results from the PaTHway trial show that palopegteriparatide improves eGFR and reduces reliance on conventional therapy in chronic hypoparathyroidi...
Today